What is hormesis and its relevance to healthy aging and longevity?

Biogerontology

Volumn 16, Issue 6, 2015, Pages 693-707

  Calabrese, Edward J ^a   Dhawan, Gaurav ^a   Kapoor, Rachna ^b   Iavicoli, Ivo ^c   Calabrese, Vittorio ^d  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b SAINT BARNABAS MEDICAL CENTER   (United States)

^c CATHOLIC UNIVERSITY   (Italy)

^d UNIVERSITY OF CATANIA   (Italy)

Author keywords

Adaptive response; Aging; Biphasic; Dose response; Hormesis; Preconditioning

Indexed keywords

DRUG;

AGING; CELL METABOLISM; DEVELOPMENTAL STAGE; HISTORY OF MEDICINE; HORMESIS; HUMAN; IONIZING RADIATION; LONGEVITY; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION DOSE DISTRIBUTION; REGULATORY MECHANISM; REVIEW; RISK ASSESSMENT; SURVIVAL RATE; ADAPTATION; AGED; ANIMAL; ISCHEMIC PRECONDITIONING; PHYSIOLOGY;

ADAPTATION, PHYSIOLOGICAL; AGED; AGING; ANIMALS; HORMESIS; HUMANS; ISCHEMIC PRECONDITIONING; LONGEVITY;

EID: 84943820014     PISSN: 13895729     EISSN: 15736768     Source Type: Journal    
DOI: 10.1007/s10522-015-9601-0     Document Type: Review

References (169)

1. Abete P, Ferrara N, Cioppa A, Ferrara P, Bianco S, Calabrese C, Cacciatore F, Longobardi G, Rengo F (1996) Preconditioning does not prevent post-ischemic dysfunction in aging heart. J Am Coll Cardiol 27:1777–1786
2. Abete P, Ferrara N, Cacciatore F, Madrid A, Bianco S, Calabrese C, Napoli C, Scognamiglio P, Bollella O, Cioppa A, Longobardi G, Rengo F (1997) Angina-induced protection against myocardial infarction in adult and senescent patients. A loss of preconditioning mechanism in aging heart? J Am Coll Cardiol 30:947–954
3. Abete P, Calabrese C, Ferrara N, Cioppa A, Pisanelli P, Cacciatore F, Longobardi G, Napoli C, Rengo F (2000) Exercise training restores IP in the aging heart. J Am Coll Cardiol 36:643–650
4. Abete P, de Santis D, Condorelli M, Napoli C, Rengo F (2002a) A four-year-old rabbit cannot be considered the right model for investigating cardiac senescence. J Am Coll Cardiol 39:1701
5. Abete P, Testa G, Ferrara N, de Santis D, Capaccio P, Viati L, Calabrese C, Cacciatore F, Longobardi G, Condorelli M, Napoli C, Rengo F (2002b) Cardioprotec tive effect of IP is preserved in food-restricted senescent rats. Am J Physiol 282:H1978–H1987
6. Abete P, Cacciatore F, Testa G, Della-Morte D, Galizia G, de Santis D, Calabrese C, Cioppa A, Fewrrara N, Rengo F (2010) Ischemic preconditioning in the aging heart: from bench to bedside. Age Res Rev 9:153–162
7. Ahuja A. (2003) Science: Some toxins may be good for us. London Times Online, 30
8. Ames BN (1987) 6 Common errors relating to environmental pollution. Regul Toxicol Pharmacol 7(4):379–383
9. Ames BN, Gold LS (1990) Chemical carcinogenesis—too many rodent carcinogens. Proc Natl Acad Sci USA 87(19):772–776
10. Ames BN, Magaw R, Gold LS (1987) Ranking possible carcinogenic hazards. Science 236(4799):271–280
11. Bailey R. (2003) The dose makes the cure. Reason Online, March 12
12. Barrientos RM, Frank MG, Crysdale NY, Chapman TR, Ahrendsen JT, Day HEW, Campeau S, Watkins LR, Patterson SL, Maier SF (2011) Little exercise, big effects: reversing aging and infection-induced memory deficits, and underlying processes. J Neurosci 31(32):11578–11586
13. Bartling B, Friedrich I, Silber RE, Simm A (2003) IP is not cardioprotective in senescent human myocardium. Ann Thorac Surg 76:105–111
14. Begley S. (2003) Scientists revisit idea that a little poison could be beneficial. Wall Str J, Vol CCXLII (121)
15. Bell J. (2004) Can a low dose of poison be a good thing? Baltimore Sun, March 15
16. Bernstein RM (2010) The big and small of it: how body size evolves. Yearbook Phys Anthrpol 53:46–62
17. Bloedau CV (1884) General medical Central 93:1362
18. Boengler K, Konietzka I, Buechert A, Heinen Y, Garcia-Dorado D, Heusch G, Schulz R (2007) Loss of IP’s cardioprotection in aged mouse hearts is associated with reduced gap junctional and mitochondrial levels of connexin 43. Am J Physiol Heart Circ Physiol 292:H1764–H1769
19. Bohme H. (1986) Hugo Schulz (8/6/1853-7/13/1932). His life and work, Ph.D. thesis, Freien University of Berlin. Berlin, Germany
20. Boyce N. (2004) Is there a tonic in the toxin? U.S. News and World Report, October 18
21. Burns PG, Krukenkamp IB, Caldarone CA, Kirvaitis RJ, Gaudette GR, Levitsky S (1996) Is the preconditioning response conserved in senescent myocardium? Ann Thorac Surg 61(3):925–929
22. Calabrese EJ (1999) Evidence that hormesis represents an “overcompensation” response to a disruption in homeostasis. Ecotoxicol Environ Saf 42:135–137
23. Calabrese EJ (2001a) Overcompensation stimulation: a mechanism for hormetic effects. Crit Rev Toxicol 31:425–470
24. Calabrese EJ (2001b) Prostaglandins: biphasic dose responses. Crit Rev Toxicol 31:475–487
25. Calabrese EJ (2001c) Estrogen and related compounds: biphasic dose responses. Crit Rev Toxicol 31:503–515
26. Calabrese EJ (2001d) Androgens: biphasic dose responses. Crit Rev Toxicol 31:517–522
27. Calabrese EJ (2001e) Adrenergic receptors: biphasic dose responses. Crit Rev Toxicol 31:523–538
28. Calabrese EJ (2001f) Adenosine: biphasic dose responses. Crit Rev Toxicol 31:539–551
29. Calabrese EJ (2001g) 5-hydroxytryptamine (serotonin): biphasic dose responses. Crit Rev Toxicol 31:553–561
30. Calabrese EJ (2001h) Dopamine: biphasic dose responses. Crit Rev Toxicol 31:563–583
31. Calabrese EJ (2001i) Opiates: biphasic dose responses. Crit Rev Toxicol 31:585–604
32. Calabrese EJ (2004) Hormesis: from marginalization to mainstream. A case for hormesis as the default dose-response model in risk assessment. Toxicol Appl Pharmacol 197:125–136
33. Calabrese EJ (2005a) Historical blunders: how toxicology got the dose-response relationship half right. Cell Mol Biol 51:643–654
34. Calabrese EJ (2005b) Toxicological awakenings: the rebirth of hormesis as a central pillar of toxicology. Toxicol Appl Pharmacol 204:1–8
35. Calabrese EJ (2007) Converging concepts: adaptive response, preconditioning, and the Yerkes-Dodson law are manifestations of hormesis. Aging Res Rev 7:8–20
36. Calabrese EJ (2008a) Hormesis and medicine. Br J Clin Pharmacol 66:594–617
37. Calabrese EJ (2008b) An assessment of anxiolytic drug screening tests: hormetic dose responses predominate. Crit Rev Toxicol 38(6):489–542
38. Calabrese EJ (2008c) Modulation of the epileptic seizure threshold: implications of biphasic dose responses. Crit Rev Toxicol 38(6):543–556
39. Calabrese EJ (2008d) Alzheimer’s disease drugs: an application of the hormetic dose-response model. Crit Rev Toxicol 38(5):419–451
40. Calabrese EJ (2008e) Dose-response features of neuroprotective agents: an integrative summary. Crit Rev Toxicol 38(4):249–252
41. Calabrese EJ (2008f) Hormesis: why it is important to toxicology and toxicologists. Environ Toxicol Chem 27(7):1451–1474
42. Calabrese EJ (2009a) The road to linearity: why linearity at low doses became the basis for carcinogen risk assessment. Arch Toxicol 83(3):203–225
43. Calabrese EJ (2009b) Getting the dose-response wrong: why hormesis became marginalized and the threshold model accepted. Arch Toxicol 83(3):227–247
44. Calabrese EJ (2010) Hormesis is central to toxicology, pharmacology and risk assessment. Hum Exper Toxicol 29:249–261
45. Calabrese EJ (2011) Toxicology rewrites its history and rethinks its future: giving equal focus to both harmful and beneficial effects. Environ Toxicol Chem 30(12):2658–2673
46. Calabrese EJ (2012) Hormesis: why it is important to biogerontologists. Biogerontology 13:215–235
47. Calabrese EJ (2013a) Biphasic dose response in biology, toxicology and medicine: accounting for their generalizability and quantitative features. Environ Poll 182:452–460
48. Calabrese EJ (2013b) Hormetic mechanisms. Crit Rev Toxicol 43(7):580–606
49. Calabrese EJ (2013c) Low doses of radiation can enhance insect lifespans. Biogerontology 14(4):365–381
50. Calabrese EJ, Baldwin LA (2000a) Chemical hormesis: its historical foundations as a biological hypothesis. Hum Exper Toxicol 19(1):2–31
51. Calabrese EJ, Baldwin LA (2000b) The marginalization of hormesis. Hum Exper Toxicol 19(1):32–40
52. Calabrese EJ, Baldwin LA (2000c) Radiation hormesis: its historical foundations as a biological hypothesis. Hum Exper Toxicol 19(1):41–75
53. Calabrese EJ, Baldwin LA (2000d) Radiation hormesis: the demise of a legitimate hypothesis. Hum Exper Toxicol 19(1):76–84
54. Calabrese EJ, Baldwin LA (2000e) Tales of two similar hypotheses: the rise and fall of chemical and radiation hormesis. Hum Exper Toxicol 19(1):85–97
55. Calabrese EJ, Baldwin LA (2000f) The effects of gamma rays on longevity. Biogerontology 1(4):309–319
56. Calabrese EJ, Baldwin LA (2001a) Scientific foundations of hormesis. Crit Rev Toxicol 31:349–695
57. Calabrese EJ, Baldwin LA (2001b) Agonist concentration gradients as a generalizable regulatory implementation strategy. Crit Rev Toxicol 31(4–5):471–473
58. Calabrese EJ, Baldwin LA (2002) Defining hormesis. Hum Exp Toxicol 21:91–97
59. Calabrese EJ, Baldwin LA (2003a) Toxicology rethinks its central belief: hormesis demands a reappraisal of the way risks are assessed. Nature 42:691–692
60. Calabrese EJ, Baldwin LA (2003b) The hormetic dose-response model is more common than the threshold model in toxicology. Toxicol Sci 71:246–250
61. Calabrese EJ, Blain R (2005) The occurrence of hormetic dose responses in the toxicological literature, the hormesis database: an overview. Toxicol Appl Pharmacol 202:289–301
62. Calabrese EJ, Blain RB (2009) Hormesis and plant biology. Environ Poll 157(1):42–48
63. Calabrese EJ, Blain RB (2011) The hormesis database: the occurrence of hormetic dose response in the toxicological literature. Regul Toxicol Pharmacol 61(1):73–81
64. Calabrese EJ, Mattson MP (2011) Hormesis provides a generalized quantitative estimate of biological plasticity. J Cell Comm Signal 5(1):25–38
65. Calabrese EJ, McCarthy ME, Kenyon E (1987) The occurrence of chemically-induced hormesis. Health Phys 52(5):531–541
66. Calabrese EJ, Staudenmayer JW, Stanek EJ III, Hoffmann GR (2006) Hormesis outperforms threshold model in National Cancer Institute antitumor drug screening database. Toxicol Sci 94(2):368–378
67. Calabrese EJ, Bachmann KA, Bailer AJ, Bolger PM, Borak J, Cai L, Cedergreen N, Cherian MG, Chiueh CC, Clarkson TW, Cook RR, Diamond DM, Doolittle DJ, Dorato MA, Duke SO, Feinendegen L, Gardner DE, Hart RW, Hastings KL, Hayes AW, Hoffmann GR, Ives JA, Jaworowski Z, Johnson TE, Jonas WB, Kaminski NE, Keller JG, Klaunig JE, Knudsen TB, Kozumbo WJ, Lettieri T, Liu S-Z, Maisseu A, Maynard KI, Masoro EJ, McClellan RO, Mehendale HM, Mothersill C, Newlin DB, Nigg HN, Oehme FW, Phalen RF, Philbert MA, Rattan SIS, Riviere JE, Rodricks J, Sapolsky RM, Scott BR, Seymour C, Sinclair DA, Smith-Sonneborn J, Snow ET, Spear L, Stevenson DE, Thomas Y, Tubiana M, Gem Williams, Mattson MP (2007) Biological stress response terminology: integrating the concepts of adaptive response and preconditioning stress within a hormetic dose–response framework. Toxicol Appl Pharmacol 222:122–128
68. Calabrese EJ, Stanek EJ III, Nascarella MA, Hoffmann GR (2008) Hormesis predicts low dose-responses better than threshold models. Intl J Toxicol 27:369–378
69. Calabrese EJ, Hoffmann GR, Stanek EJ III, Nascarella MA (2010) Hormesis in high-throughput screening of antibacterial compounds in E. coli. Hum Exp Toxicol 29:667–677
70. Chrysostomou V, Kezic JM, Trounce IA, Crowston JG (2014) Forced exercise protects the aged optic nerve against intraocular pressure injury. Neurobiol Aging 35:1722–1725
71. Clark AJ (1933) Mode of action of drugs on cells. Arnold, London
72. Clark AJ (1937) General pharmacology. In: Hefftner AJ (ed) Handbuch der Experimentellen Pharmakologie (Handbook of Experimental Pharmacology). Verlig Von Julius Springer, Berlin
73. Congdon CC (1987) A review of certain low-level ionizing radiation studies in mice and guinea pig. Health Phys 52:593–597
74. Cook G (2003) A scientist finds benefit in small doses of toxins. Boston Globe 12:A16–A18
75. Cork JM (1957) Gamma-radiation and longevity of the flour beetle. Radiat Res 7:551–557
76. Costantini D (2014) Oxidative stress and hormesis in evolutionary ecology and physiology. A marriage between mechanistic and evolutionary approaches. Springer, Berlin
77. Coulter HL (1972) Homoeopathic medicine. Formur, St. Louis
78. Coulter HL (1982) Divided legacy: the conflict between homoeopathy and the American Medical Association. North Atlantic Books, Berkeley
79. Crump T (2003) Contemporary medicine as presented by its practitioners themselves. Leipzig, 1923:217-250, Hugo Schulz, NIH Library Translation (NIH-98-134). Nonlinear Biol Toxicol Med 1:295–318
80. Cypser JR, Johnson TE (2002) Multiple stressors in Caenorhabditis elegans induce stress hormesis and extended longevity. J Gerontol Ser A 57(3):B109–B114
81. Davey WP (1917) The effect of X-rays on the length of life of Tribolium confusum. J Exp Zool 22(3):573–592
82. Davey WP (1919) Prolongation of life of Tribolium confusum apparently due to small doses of X-rays. J Exp Zool 28(3):447–458
83. Demirovic D, Rattan SIS (2011) Curcumin induces stress response and hermetically modulates wound healing ability of human skin fibroblasts undergoing ageing in vitro. Biogerontology 12:437–444
84. Ebrahim Z, Yellon DM, Baxter GF (2007) IP is lost in aging hypertensive rat heart: independent effects of aging and longstanding hypertension. Exp Gerontol 42:807–814
85. Elliott KC (2011) Is a little pollution good for you? Incorporating societal values into environmental research. Oxford University Press, London
86. Fenton RA, Dickson EW, Meyer TE, Dobson JG Jr (2000) Aging reduces the cardioprotective effect of IP in the rat heart. J Mol Cell Cardiol 32:1371–1375
87. Fosslien E (2002) Establishment, maintenance, and remodeling of curvature in biology. Med Hypotheses 59(3):233–238
88. Fosslien E (2009) The hormetic morphogen theory of curvature and the morphogenesis and pathology of tubular and other curved structures. Dose Response 7(4):307–331
89. Furst A (1987) Hormetic effects in pharmacology—pharmacological inversions as prototypes for hormesis. Health Phys 52(5):527–530
90. Gadhia PK (1998) Possible age-dependent adaptive response to a low dose of X-rays in human lymphocytes. Mutagenesis 13(2):151–152
91. Garcia-Mesa Y, Pareja-Galeano H, Bonet-Costa V, Revilla S, Gomez-Cabrera MC, Gambini J, Gimenez-Llort L, Cristofol R, Vina J, Sanfeliu C (2014) Physical exercise neuroprotects ovariectomized 3xTg-AD mice through BDNF mechanisms. Psychoneuroendocrinology 45:154–166
92. He Z, Meschia JF, Brott TG, Dickson DW, McKinney M (2006) Aging is neuroprotective during global ischemia but leads to increased caspase-3 and apoptotic activity in hippocampal neurons. Curr Neurovasc Res 3(3):181–186
93. He Z, Crook JE, Meschia JF, Brott TG, Dickson DW, McKinney M (2015) Aging blunts ischemic-preconditioning-induced neuroprotection following transient global ischemia in rats. Curr Neurovasc Res 2(5):365–374
94. Heusch G, Botker HE, Przyklenk K, Redington A, Yellon D (2015) Remote ischemic conditioning. J Am Coll Cardiol 65(2):177–195
95. Hively W. (2003) Is radiation good for you? Discover, 74–80
96. Hunt PR, Son TG, Wilson MA, Yu Q-S, Wood WH, Zhang Y, Becker KG, Greig NH, Mattson MP, Camandola S, Wolkow CA (2011) Extension of lifespan in C. elegans by naphthoquinones that act through stress hormesis mechanisms. PLoS One 6(7):e21922
97. Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, Nishioka K, Kouno Y, Umemura T, Nakamura S, Sato H (2001) Diabetes mellitus prevents ischemic preconditioning in patients with a first acute anterior wall myocardial infarction. J Am Coll Cardiol 38:1007–1011
98. Jahangir A, Sagar S, Terzic A (2007) Aging and cardioprotection. J Appl Physiol 103:2120–2128
99. Kahn A, Olsen A (2010) Stress to the rescue: is hormesis a ‘cure’ for aging? Dose Response 8(1):48–52
100. Kaiser J (2003) Sipping from a poisoned chalice. Science 302:276–279
101. Kitani K, Minami C, Isobe K-I, Maehara K, Kanai S, Ivy GO, Carrillo M-C (2002) Why (-)deprenyl prolongs survivals of experimental animals: increase of antioxidant enzymes in brain and other body tissues as well as mobilization of various humoral factors may lead to systemic anti-aging effects. Mech Ageing Dev 123:1087–1100
102. Kitani K, Kanai S, Miyasaka K, Carrillo M-C, Ivy GO (2005) Dose-dependency of life span prolongation of F344/DuCrj rats injected with (-)deprenyl. Biogenerontol 6:297–302
103. Krenz M, Baines C, Kalogeris T, Korthuis RJ. (2013) Cell survival programs and ischemia/reperfusion. Hormesis, preconditioning, and cardioprotection. In: Granger DN & Granger J (ed) Colloquium series on integrated systems physiology: from molecule to function to disease, Lecture #44, Digital Library. Morgan & Claypool Life Sciences
104. Kubo M, Li T-S, Kurazumi H, Takemoto Y, Ohshima M, Murata T, Katsura S, Morikage N, Furutani A, Hamano K (2012) Hypoxic preconditioning enhances angiogenic potential of bone marrow cells with aging-related functional impairment. Circ J 76:986–994
105. Kwak HB, Song W, Lawler JM (2006) Exercise training attenuates age-induced elevation in Bax/Bcl-2 ratio, apoptosis, and remodeling in the rat heart. FASEB J 20:791–793
106. Lambert E (2003) A pinch of poison. Forbes Life Online 22:236–237
107. Le Bourg E (2011) Using Drosophila melanogaster to study the positive effects of mild stress on aging. Exp Gerontol 46:345–348
108. Le Bourg E, Rattan S (2009) Mild stress in healthy aging: applying hormesis in aging research and interventions. Springer, New York
109. Lee TM, Su SF, Chou TF, Lee YT, Tsai CH (2002) Loss of preconditioning by attenuated activation of myocardial ATP-sensitive potassium channels in elderly patients undergoing coronary angioplasty. Circulation 105:334–340
110. Lehman AJ, Fitzhugh OG (1953) 100-fold margin of safety. Assoc Food Drug Off Quart Bull 17(2):33–35
111. Long P, Nguyen Q, Thurow C, Broderick TL (2002) Caloric restriction restores the cardioprotective effect of preconditioning in the rat heart. Mech Ageing Dev 123:1411–1443
112. Longobardi G, Abete P, Ferrara N, Papa A, Rosiello R, Furgi G, Calabrese C, Cacciatore F, Rengo F (2000) “Warm-up” phenomenon in adult and elderly patients with coronary artery disease: further evidence of the loss of “IP” in the aging heart. J Gerontol A 55:M124–M129
113. Loubani M, Ghosh S, Galinanes M (2003) The aging human myocardium: tolerance to ischemia and responsiveness to ischemic preconditioning. J Thorac Cardiovasc Surg 126(1):143–147
114. Lu R, Hu CP, Deng HW, Li YJ (2001) Calcitonin gene-related peptide-mediated IP in the rat heart: influence of age. Regul Pept 99:183–189
115. Luckey TD (1980) Hormesis with ionizing radiation. CRC, Boca Raton
116. Luckey TD (1991) Radiation hormesis. CRC, Boca Raton
117. Luckey TD, Venugopal V, Hutcheson D (1975) Heavy metal toxicity, safety and hormology. Academic Press, New York
118. Marques FZ, Markus MA, Morris BJ (2010) Hormesis as a pro-health aging intervention in human beings? Dose Response 8(1):28–33
119. Masoro EJ (1998) Hormesis and the antiaging action of dietary restriction. Exp Gerontol 33(1–2):61–66
120. Masoro EJ (2000) Caloric restriction and aging: an update. Exp Gerontol 35(3):299–305
121. Masoro EJ (2005) Overview of caloric restriction and ageing. Mech Ageing Dev 126(9):913–922
122. Mattson M, Calabrese EJ (2010) Hormesis: a revolution in biology, toxicology and medicine. Springer, New York
123. McCully JD, Uematsu M, Parker RA, Levitsky S (1998) Adenosine-enhanced IP provides enhanced cardioprotection in the aged heart. Ann Thorac Surg 66:2037–2043
124. Meng R, Ding Y, Asmaro K, Brogan D, Meng L, Sui M, Shi J, Duan Y, Sun Z, Yu Y, Jia J, Ji X (2015) Ischemic conditioning is safe and effective for octo- and nonagenarians in stroke prevention and treatment. Neurotherapeutics 12:667–677
125. Miura Y (2004) Oxidative stress, radiation-adaptive responses, and aging. J Radiat Res 45:357–372
126. Miura Y, Endo T (2010) Survival responses to oxidative stress and aging. Geriatr Gerontol Int 10(Suppl 1):S1–S9
127. Miura Y, Abe K, Urano S, Furuse T, Noda Y, Tatsumi K, Suzuki S (2002) Adaptive response and the influence of ageing: effects of low-dose irradiation on cell growth of cultured glial cells. Int J Radiat Biol 78(10):913–921
128. Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia—a delay of lethal cell injury in ischemic myocardium. Circulation 74:1124–1136
129. Napoli C, Liguori A, Cacciatore F, Rengo F, Ambrosio G, Abete P (1999) Warm-up phenomenon detected by electrocardiographic ambulatory monitoring in adult and older patients. J Am Geriatr Soc 47:1114–1117
130. Newton IG, Forbes ME, Linville MC, Pang H, Tucker EW, Riddle DR, Brunso-Bechtold JK (2008) Effects of aging and caloric restriction on dentate gyrus synapses and glutamate receptor subunits. Neurobiol Aging 29:1308–1318
131. O’Brien JD, Howlett SE (2008) Simulated ischemia-induced preconditioning of isolated ventricular myocytes from young adult and aged Fischer-344 rat hearts. Am J Physiol Heart Circ Physiol 295:H768–H777
132. Olsen A, Vantipalli MC, Lithgow GJ (2006) Lifespan extension of Caenorhabditis elegans following repeated mild hormetic heat treatments. Biogerontology 7(4):221–230
133. Pardon MC (2010) Hormesis is applicable as a pro-health aging intervention in mammals and human beings. Dose Response 8(1):22–27
134. Park S (2010) Effect of preconditioning regular exercise on ischemic stroke in aged brain. J Exerc Nutr Biochem 14(1):39–43
135. Pepe S (2001) Dysfunctional IP mechanisms in aging. Cardiovasc Res 49:11–14
136. Pike J. (2004) Can toxins lead to healthier lives? Insight Magazine, 6
137. Powers SK, Quindry J, Hamilton K (2004) Aging, exercise, and cardioprotection. Ann NY Acad Sci 019:42–470
138. Raloff J (2007) Counterintuitive toxicity. Science News Online 171:40
139. Rattan SIS (2012) Rationale and methods of discovering hormetins as drugs for healthy ageing. Expert Opin Drug Discov 7(5):439–448
140. Rattan SIS, Le Bourg E (2014) Hormesis in health and disease. CRC Press, Boca Raton
141. Renner R (2003) Hormesis: Nietzsche’s toxicology. Sci Am. 289:28–30
142. Ristow M, Schmeisser S (2011) Extending life span by increasing oxidative stress. Free Radic Biol Med 51(2):327–336
143. Roberge M-C, Messier C, Staines WA, Plamondon H (2008) Food restriction induces long-lasting recovery of spatial memory deficits following global ischemia in delayed matching and non-matching-to-sample radial arm maze tasks. Neuroscience 156:11–29
144. Roberts R. (2003) Here’s to your health. St. Louis Post Dispatch, January 9
145. Rohrbach S, Aslam M, Niemann B, Schulz R (2014) Impact of caloric restriction on myocardial ischaemia/reperfusion injury and new therapeutic options to mimic its effects. Brit J Pharmacol 171:2964–2992
146. Sagan LA (1989) On radiation, paradigms, and hormesis. Science 245(4918):574–621
147. Salminen A, Kaarniranta K (2010) ER stress and hormetic regulation of the aging process. Ageing Res Rev 9(3):211–217
148. Sarup P, Loeschcke V (2011) Life extension and the position of the hormetic zone depends on sex and genetic background in Drosophila melanogaster. Biogerontology 12:109–117
149. Saunders C (2010) Radiation hormesis and the linear no-threshold assumption. Springer, New York
150. Schulman D, Latchman DS, Yellon DM (2001) Effect of aging on the ability of preconditioning to protect rat hearts from ischemia-reperfusion injury. Am J Physiol 28:H1630–H1636
151. Schulz H (1887) Zur Lehre von der Arzneiwirkung. Virchows Arch Pathol Anat Physiol Klin Med 108:423–445
152. Schulz H (1888) Uber Hefegifte. Pflugers Archiv—fur die gesamte Physiologie des Menschen und der Tiere 42:517–541
153. Shackell LF (1923) Studies in protoplasm poisoning I. Phenols. J Gen Physiol 5:783–805
154. Shackell LF (1925) The relation of dosage to effect II. J Pharmacol Exp Ther 15:275–288
155. Shackell LF, Williamson W, Deitchmann MM, Katzman GM, Dleinman BS. (1924/1925) The relation of dosage to effect. J Pharmacol Exp Ther 23–24:53–56
156. Southam CM, Erhlich J (1943) Effects of extracts of western red-cedar heartwood on certain wood-decaying fungi in culture. Phytophathology 33:517–524
157. Stebbing ARD (1976) Effects of low metal levels on a clonal hydroid. J Marine Biol Assoc UK 56(4):977–994
158. Stebbing ARD (1982) Hormesis—the stimulation of growth by low-levels of inhibitors. Sci Total Environ 22(3):213–234
159. Stebbing ARD (1987) Growth hormesis—a by-product of control. Health Phys 52:543–547
160. Stebbing ARD (1998) A theory for growth hormesis. Mutat Res 403:249–258
161. Stebbing A (2011) A cybernetic view of biological growth: the Maia hypothesis. Cambridge Publishers, London
162. Stipp D (2003) A little poison can be good for you. Fortune 147:54–55
163. Szabadi E (1977) A model of two functionally antagonistic receptor populations activated by the same agonist. J Theor Biol 69:101–112
164. Tani M, Suganuma Y, Hasegawa H, Shinmura K, Hayashi Y, Guo X, Nakamura Y (1997) Changes in ischemic tolerance and effects of IP in middle-aged rat hearts. Circulation 95:2559–2566
165. Tesic V, Perovic M, Lazic D, Kojic S, Smiljanic K, Ruzdijic S, Rakic L, Kanazir S (2015) Long-term intermittent feeding restores impaired GR signaling in the hippocampus of aged rat. J Ster Biochem Mol Biol 49:43–52
166. Vasconcelos AR, Kinoshita PF, Yshii LM, Orellana AMM, Bohmer AE, de Sa Lima L, Alves R, Andreotti DZ, Marcourakis T, Scavone C, Kawamoto EM (2015) Effects of intermittent fasting on age-related changes on Na, K-ATPase activity and oxidative status induced by lipopolysaccharide in rat hippocampus. Neurobiol Aging 36:1914–1923
167. Wels P (1933) The life time work of Hugo Schulz. Naunyn-Schmiedebergs Arch Pharmakol 170:744–757
168. Wolff S (1989) Are radiation-induced effects hormetic. Science 245(4918):575–621
169. Yin Z, Gao H, Wang H, Li L, Di C, Luan R, Tao L (2009) Ischaemic post-conditioning protects both adult and aged Sprague-Dawley rat heart from ischaemia-reperfusion injury through the phosphatidylinositol 3-kinase-Akt and glycogen synthase kinase-3β pathways. Clin Exp Pharmacol Physiol 36:756–763